Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 411,328 | 358,711 | 310,463 | 331,339 | 391,866 |
| Cost of Goods | 103,661 | 62,500 | 64,424 | 13,793 | N/A |
| Gross Profit | 307,667 | 296,211 | 246,039 | 317,546 | 391,866 |
| Operating Expenses | 144,583 | 129,844 | 132,578 | -155,352 | 16,763 |
| Operating Income | 163,745 | 166,867 | 113,885 | 473,691 | 375,103 |
| Interest Expense | 16,698 | 22,209 | 19,157 | 15,789 | 19,070 |
| Other Income | 179,815 | -107,270 | 99,370 | -170,953 | 89,243 |
| Pre-tax Income | 326,862 | 37,388 | 194,098 | 286,949 | 445,276 |
| Income Tax | 55,697 | 13,996 | 14,376 | 66,687 | 76,439 |
| Net Income Continuous | 271,165 | 23,392 | 179,722 | 220,262 | 368,837 |
| Minority Interests | N/A | N/A | N/A | 6,341 | 102,983 |
| Net Income | $271,165 | $23,392 | $179,722 | $213,921 | $265,854 |
| EPS Basic Total Ops | 4.02 | 0.37 | 2.75 | 3.07 | 3.24 |
| EPS Basic Continuous Ops | 4.02 | 0.37 | 2.75 | 3.16 | 4.49 |
| EPS Diluted Total Ops | 3.30 | 0.36 | 2.20 | 2.37 | 2.87 |
| EPS Diluted Continuous Ops | 3.20 | 0.32 | 2.07 | 2.31 | 3.91 |
| EPS Diluted Before Non-Recurring Items | 3.93 | 2.37 | 2.25 | 1.60 | 3.28 |
| EBITDA(a) | $205,860 | $208,830 | $151,655 | $495,258 | $398,071 |